Administration of Ligilactobacillus salivarius CECT 30632 to elderly during the COVID-19 pandemic: Nasal and fecal metataxonomic analysis and fatty acid profiling
Elderly was the most affected population during the first COVID-19 and those living in nursing homes represented the most vulnerable group, with high mortality rates, until vaccines became available. In a previous article, we presented an open-label trial showing the beneficial effect of the strain...
Main Authors: | Marta Mozota, Irma Castro, Natalia Gómez-Torres, Rebeca Arroyo, Isabel Gutiérrez-Díaz, Susana Delgado, Juan Miguel Rodríguez, Claudio Alba |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1052675/full |
Similar Items
-
A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines
by: Juan M. Rodríguez, et al.
Published: (2023-02-01) -
Immunomodulation of the Vaginal Ecosystem by <i>Ligilactobacillus salivarius</i> CECT 30632 Improves Pregnancy Rates among Women with Infertility of Unknown Origin or Habitual Abortions
by: Leónides Fernández, et al.
Published: (2023-01-01) -
Ligilactobacillus salivarius 2102-15 complete genome sequence data
by: Andrey V. Karlyshev, et al.
Published: (2023-10-01) -
Complete genome sequence of bacteriocin-producing Ligilactobacillus salivarius B4311 isolated from fecal samples of broiler chicken with anti-listeria activity
by: Subin Han, et al.
Published: (2024-01-01) -
Administration of <i>Ligilactobacillus salivarius</i> MP101 in an Elderly Nursing Home during the COVID-19 Pandemic: Immunological and Nutritional Impact
by: Marta Mozota, et al.
Published: (2021-09-01)